SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michael S. Gordon, Timothy W. Kinlock, Robert P. Schwartz, Terrence T. Fitzgerald, Kevin E. O’Grady, Frank J. Vocci, A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry, Drug and Alcohol Dependence, 2014, 142, 33

    CrossRef

  2. 2
    Michelle R. Lofwall, Sharon L. Walsh, A Review of Buprenorphine Diversion and Misuse, Journal of Addiction Medicine, 2014, 8, 5, 315

    CrossRef

  3. 3
    Eric J. Lavonas, S. Geoffrey Severtson, Erin M. Martinez, Becki Bucher-Bartelson, Marie-Claire Le Lait, Jody L. Green, Lenn E. Murrelle, Theodore J. Cicero, Steven P. Kurtz, Andrew Rosenblum, Hilary L. Surratt, Richard C. Dart, Abuse and diversion of buprenorphine sublingual tablets and film, Journal of Substance Abuse Treatment, 2014, 47, 1, 27

    CrossRef

  4. 4
    M. Soledad Cepeda, Daniel Fife, Mary A. Kihm, Greg Mastrogiovanni, Yingli Yuan, Comparison of the Risks of Shopping Behavior and Opioid Abuse Between Tapentadol and Oxycodone and Association of Shopping Behavior and Opioid Abuse, The Clinical Journal of Pain, 2014, 30, 12, 1051

    CrossRef

  5. 5
    Ayman Fareed, Pamela Eilender, Bethany Ketchen, Ann Marie Buchanan-Cummings, Kelly Scheinberg, Kelli Crampton, Abigail Nash, Hilaire Shongo-Hiango, Karen Drexler, Factors Affecting Noncompliance With Buprenorphine Maintenance Treatment, Journal of Addiction Medicine, 2014, 8, 5, 345

    CrossRef

  6. 6
    Alex M. Secora, Catherine M. Dormitzer, Judy A. Staffa, Gerald J. Dal Pan, Measures to quantify the abuse of prescription opioids: a review of data sources and metrics, Pharmacoepidemiology and Drug Safety, 2014, 23, 12
  7. 7
    Shan-Estelle Brown, Frederick L. Altice, Self-Management of Buprenorphine/Naloxone Among Online Discussion Board Users, Substance Use & Misuse, 2014, 49, 8, 1017

    CrossRef

  8. 8
    Lydia Turner, Stefan P. Kruszewski, G. Caleb Alexander, Trends in the use of buprenorphine by office-based physicians in the United States, 2003–2013, The American Journal on Addictions, 2014, 23, 6
  9. 9
    Bethany Foster, Robert Twycross, Mary Mihalyo, Andrew Wilcock, Buprenorphine, Journal of Pain and Symptom Management, 2013, 45, 5, 939

    CrossRef

  10. 10
    Amy Zosel, Becki Bucher Bartelson, Elise Bailey, Steven Lowenstein, Rick Dart, Characterization of Adolescent Prescription Drug Abuse and Misuse Using the Researched Abuse Diversion and Addiction-Related Surveillance (RADARS®) System, Journal of the American Academy of Child & Adolescent Psychiatry, 2013, 52, 2, 196

    CrossRef

  11. 11
    Zev Schuman-Olivier, Hilary Connery, Margaret L. Griffin, Steve A. Wyatt, Alan A. Wartenberg, Jacob Borodovsky, John A. Renner, Roger D. Weiss, Clinician beliefs and attitudes about buprenorphine/naloxone diversion, The American Journal on Addictions, 2013, 22, 6
  12. 12
    M. Soledad Cepeda, Daniel Fife, Lien Vo, Gregory Mastrogiovanni, Yingli Yuan, Comparison of Opioid Doctor Shopping for Tapentadol and Oxycodone: A Cohort Study, The Journal of Pain, 2013, 14, 2, 158

    CrossRef

  13. 13
    M. Soledad Cepeda, Daniel Fife, Qianli Ma, Patrick B. Ryan, Comparison of the Risks of Opioid Abuse or Dependence Between Tapentadol and Oxycodone: Results From a Cohort Study, The Journal of Pain, 2013, 14, 10, 1227

    CrossRef

  14. 14
    Helen Baldwin, Paul Duffy, Drug treatment practitioners’ perceptions of methadone diversion and their responses to it, Drugs: Education, Prevention, and Policy, 2013, 20, 1, 22

    CrossRef

  15. 15
    Nickolas Zaller, Michelle McKenzie, Peter D. Friedmann, Traci C. Green, Samuel McGowan, Josiah D. Rich, Initiation of buprenorphine during incarceration and retention in treatment upon release, Journal of Substance Abuse Treatment, 2013, 45, 2, 222

    CrossRef

  16. 16
    Samantha Lee, Wendy Klein-Schwartz, Christopher Welsh, Suzanne Doyon, Medical Outcomes Associated with Nonmedical Use of Methadone and Buprenorphine, The Journal of Emergency Medicine, 2013, 45, 2, 199

    CrossRef

  17. 17
    Harlan Matusow, Samuel L. Dickman, Josiah D. Rich, Chunki Fong, Dora M. Dumont, Carolyn Hardin, Douglas Marlowe, Andrew Rosenblum, Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes, Journal of Substance Abuse Treatment, 2013, 44, 5, 473

    CrossRef

  18. 18
    Céline Eiden, Yves Léglise, Lisa Bertomeu, Vivianne Clavel, Jean-Luc Faillie, Pierre Petit, Hélène Peyrière, New Formulation of Methadone for Opioid Dependence in France: Acceptability and Diversion/Misuse Liability, Thérapie, 2013, 68, 2, 107

    CrossRef

  19. 19
    Becky L. Genberg, Mirinda Gillespie, Charles R. Schuster, Chris-Ellyn Johanson, Jacquie Astemborski, Gregory D. Kirk, David Vlahov, Shruti H. Mehta, Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland, Addictive Behaviors, 2013, 38, 12, 2868

    CrossRef

  20. 20
    Eric J. Lavonas, William Banner, Pamela Bradt, Becki Bucher-Bartelson, Kimberly R. Brown, Pradeep Rajan, Lenn Murrelle, Richard C. Dart, Jody L. Green, Root Causes, Clinical Effects, and Outcomes of Unintentional Exposures to Buprenorphine by Young Children, The Journal of Pediatrics, 2013, 163, 5, 1377

    CrossRef

  21. 21
    Amy Yang, Cynthia L. Arfken, Chris-Ellyn Johanson, Steps Physicians Report Taking to Reduce Diversion of Buprenorphine, The American Journal on Addictions, 2013, n/a

    CrossRef

  22. 22
    Amy Yang, Cynthia L. Arfken, Chris-Ellyn Johanson, Steps Physicians Report Taking to Reduce Diversion of Buprenorphine, The American Journal on Addictions, 2013, 22, 3
  23. 23
    Mark A. Sembower, Michelle D. Ertischek, Chloe Buchholtz, Nabarun Dasgupta, Sidney H. Schnoll, Surveillance of Diversion and Nonmedical Use of Extended-Release Prescription Amphetamine and Oral Methylphenidate in the United States, Journal of Addictive Diseases, 2013, 32, 1, 26

    CrossRef

  24. 24
    Brent A. Moore, Declan T. Barry, Lynn E. Sullivan, Patrick G. OʼConnor, Christopher J. Cutter, Richard S. Schottenfeld, David A. Fiellin, Counseling and Directly Observed Medication for Primary Care Buprenorphine Maintenance, Journal of Addiction Medicine, 2012, 6, 3, 205

    CrossRef

  25. 25
    Chris-Ellyn Johanson, Cynthia L. Arfken, Salvatore di Menza, Charles Roberts Schuster, Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians, Drug and Alcohol Dependence, 2012, 120, 1-3, 190

    CrossRef

  26. 26
    V. Pauly, V. Pradel, L. Pourcel, S. Nordmann, E. Frauger, M. Lapeyre-Mestre, J. Micallef, X. Thirion, Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France, Drug and Alcohol Dependence, 2012, 126, 1-2, 13

    CrossRef

  27. 27
    Raminta Daniulaityte, Russel Falck, Robert G. Carlson, Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids, Drug and Alcohol Dependence, 2012, 122, 3, 201

    CrossRef

  28. 28
    Robert Roose, Liza Fuentes, Mandeep Cheema, Messages About Methadone and Buprenorphine in Reality Television: A Content Analysis of Celebrity Rehab With Dr. Drew, Substance Use & Misuse, 2012, 47, 10, 1117

    CrossRef

  29. 29
    Gary M. Reisfield, Charles K. Friedman, Methadone in the Chronic Pain Patient With a Substance Use Disorder, Journal of Pain and Palliative Care Pharmacotherapy, 2012, 26, 4, 368

    CrossRef

  30. 30
    Sharon Stancliff, Herman Joseph, Chunki Fong, Terry Furst, Sandra D. Comer, Perrine Roux, Opioid Maintenance Treatment as a Harm Reduction Tool for Opioid-Dependent Individuals in New York City: The Need to Expand Access to Buprenorphine/Naloxone in Marginalized Populations, Journal of Addictive Diseases, 2012, 31, 3, 278

    CrossRef

  31. 31
    Paul Duffy, Helen Baldwin, The nature of methadone diversion in England: a Merseyside case study, Harm Reduction Journal, 2012, 9, 1, 3

    CrossRef

  32. 32
    Michelle R. Lofwall, Martha J. Wunsch, Paul A. Nuzzo, Sharon L. Walsh, Efficacy of continuing medical education to reduce the risk of buprenorphine diversion, Journal of Substance Abuse Treatment, 2011, 41, 3, 321

    CrossRef

  33. 33
    Sandra Nordmann, Elisabeth Frauger, Vanessa Pauly, Frank Rouby, Michel Mallaret, Joëlle Micallef, Xavier Thirion, Les systèmes d’évaluation de l’abus et de la dépendance des médicaments psychoactifs, Thérapie, 2011, 66, 3, 263

    CrossRef

  34. 34
    Lisa S. Middleton, Paul A. Nuzzo, Michelle R. Lofwall, David E. Moody, Sharon L. Walsh, The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers, Addiction, 2011, 106, 8
  35. 35
    Julie Golembiewski, Andrei M. Rakic, Sublingual Buprenorphine, Journal of PeriAnesthesia Nursing, 2010, 25, 6, 413

    CrossRef

  36. 36
    Pier Paolo Pani, Emanuela Trogu, Icro Maremmani, Matteo Pacini, QTc interval screening for cardiac risk in methadone treatment of opioid dependence, The Cochrane Library,